 U.S. News & World Report | Bristol Halts Test Drug for Hepatitis Wall Street Journal By JONATHAN D. ROCKOFF · Bristol-Myers Squibb Co. suffered a serious setback in its multibillion-dollar efforts to find new treatments for a deadly liver disease, suspending testing of a pill for hepatitis C after a patient's heart failed. The pill was ... Bristol-Myers exec charged with insider trading Bristol-Myers suspends hepatitis C treatment study, cites possible cardiac concern Like Gilead, Achillion Should Trade Up On Bad News For Bristol-Myers, Idenix ... |
Thursday, August 2, 2012
Bristol Halts Test Drug for Hepatitis - Wall Street Journal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment